Atrial Fibrillation Trial, Recruiting NCT04528511 Sponsor: Shanghai 10th People's Hospital Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT04528511
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 18 years old
  • People who were hospitalised for a heart attack (either a severe type called STEMI or a less severe type called NSTEMI) and developed a new irregular heart rhythm called atrial fibrillation (AF) for the first time during that hospital stay
  • People who received continuous heart rhythm monitoring in hospital for at least 5 days
  • People who are willing to give their written agreement to take part in the trial

Who may not be able to join:

  • People who had atrial fibrillation (an irregular heartbeat) before their heart attack
  • People with a history of rheumatic valve disease (a heart valve problem caused by rheumatic fever)
  • People with a condition called sick sinus syndrome, where the heart's natural pacemaker does not work properly
  • People who needed emergency open-heart bypass surgery
  • People diagnosed with cancer where life expectancy is less than one year
  • People who declined continuous heart rhythm monitoring during their hospital stay, meaning their heart rhythm data could not be collected
  • People who declined or are medically unable to have a procedure called PCI (a procedure to open blocked heart arteries using a small tube inserted through the skin)
  • People who passed away during the hospital stay for their heart attack

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yidong Wei, M.D., Ph.D., Department of Cardiology, Shanghai Tenth People's Hospital

Phone: +86-188-0179-0469

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai 10th People's Hospital
Registry
ClinicalTrials.gov
Start date
1 October 2020
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

All-cause death

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov